Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.73 |
| ▸ | NPC1L1 | Q9UHC9 | 2/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | CDC25A | P30304 | 6/20 | 0.61 |
| ▸ | VDR | P11473 | 1/20 | 0.58 |
| ▸ | FNTA | P49354 | 5/20 | 0.55 |
| ▸ | FNTB | P49356 | 5/20 | 0.55 |
| ▸ | POLA1 | P09884 | 2/20 | 0.54 |
| ▸ | CDC25B | P30305 | 1/20 | 0.51 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.50 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.48 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11420923 | 1.00 | USP2 (0.73) | USP2NPC1L1LMNACDC25AVDR | |
| SCHEMBL11413673 | 1.00 | USP2 (0.73) | USP2NPC1L1LMNACDC25AVDR | |
| SCHEMBL11579247 | 0.93 | NPC1L1 (0.63) | USP2NPC1L1LMNACDC25AVDR | |
| SCHEMBL31504626 | 0.91 | NPC1L1 (0.60) | USP2NPC1L1LMNACDC25AVDR | |
| SCHEMBL24998517 | 0.88 | USP2 (0.59) | USP2NPC1L1LMNACDC25AVDR | |
| SCHEMBL14771067 | 0.88 | USP2 (0.59) | USP2NPC1L1LMNACDC25AVDR | |
| SCHEMBL19685131 | 0.88 | USP2 (0.59) | USP2NPC1L1LMNACDC25AVDR | |
| SCHEMBL18092599 | 0.88 | USP2 (0.59) | USP2NPC1L1LMNACDC25AVDR | |
| SCHEMBL18575781 | 0.88 | USP2 (0.59) | USP2NPC1L1LMNACDC25AVDR | |
| SCHEMBL25702700 | 0.88 | USP2 (0.59) | USP2NPC1L1LMNACDC25AVDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6274118-B1 | INJECTING PATIENT HAVING ENDOCRINE CANCER IN NON-PROSTATIC TISSUE WITH BIOLOGICAL BINDING UNITS WHICH BIND TO PROSTATE SPECIFIC ANTIGEN PRODUCED BY NON-PROSTATIC TISSUE | NORDION INTERNATIONAL INC. (CA) | 2001-08-14 | — | — | US | disclosed |
| WO-1995002424-A1 | LOCALIZATION AND THERAPY OF NON-PROSTATIC ENDOCRINE CANCER WITH AGENTS DIRECTED AGAINST PROSTATE SPECIFIC ANTIGEN | NORDION INTERNATIONAL INC. (CA) | 1995-01-26 | — | — | WO | disclosed |
| US-4212815-A | REACTING A KETONE WITH AN N,N-DISUBSTITUTED AMINOSULFUR TRIFLUORIDE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1980-07-15 | — | — | US | disclosed |